Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.
暂无分享,去创建一个
Robert Langer | Marc D Succi | R. Langer | M. Webber | M. Succi | Beata Chertok | B. Chertok | Matthew J Webber | Beata Chertok
[1] J. Carmena. Advances in Neuroprosthetic Learning and Control , 2013, PLoS biology.
[2] Daniel G Anderson,et al. Injectable nano-network for glucose-mediated insulin delivery. , 2013, ACS nano.
[3] Dennis E Discher,et al. Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .
[4] Z. John Shen,et al. Review of Silicon Power Semiconductor Technologies for Power Supply on Chip and Power Supply in Package Applications , 2013, IEEE Transactions on Power Electronics.
[5] B. Brown,et al. Expanded applications, shifting paradigms and an improved understanding of host-biomaterial interactions. , 2013, Acta biomaterialia.
[6] M. Masuda,et al. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. , 2013, Japanese journal of clinical oncology.
[7] P. Gualtieri,et al. Clustering and turbulence modulation in particle laden shear flows , 2011, Journal of Fluid Mechanics.
[8] Arianna Menciassi,et al. Wearable and implantable pancreas substitutes , 2013, Journal of Artificial Organs.
[9] Sergio Martinoia,et al. Modular Neuronal Assemblies Embodied in a Closed-Loop Environment: Toward Future Integration of Brains and Machines , 2012, Front. Neural Circuits.
[10] Samuel I Stupp,et al. Advances in cryogenic transmission electron microscopy for the characterization of dynamic self-assembling nanostructures. , 2012, Current opinion in colloid & interface science.
[11] Rajiv Ranganathan,et al. The Body-Machine Interface: A New Perspective on an Old Theme , 2012, Journal of motor behavior.
[12] D. Ingber,et al. Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels , 2012, Science.
[13] Jianzhong Lin,et al. Nanoparticle Migration in a Fully Developed Turbulent Pipe Flow Considering the Particle Coagulation , 2012 .
[14] Mihai Irimia-Vladu,et al. Green and biodegradable electronics , 2012 .
[15] C. Bettinger,et al. Biomaterials‐Based Electronics: Polymers and Interfaces for Biology and Medicine , 2012, Advanced healthcare materials.
[16] Robert Langer,et al. Materials for Diabetes Therapeutics , 2012, Advanced healthcare materials.
[17] Percy A. Knolle,et al. Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.
[18] Robert Langer,et al. First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip , 2012, Science Translational Medicine.
[19] S. Wan,et al. Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta‐analysis of randomised controlled trials , 2012, International journal of clinical practice.
[20] N. Jørgensen,et al. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans , 2012, Scandinavian journal of clinical and laboratory investigation.
[21] S M Moghimi,et al. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. , 2012, Annual review of pharmacology and toxicology.
[22] P. Flatt,et al. Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine , 2011, Diabetes Care.
[23] D. Gold,et al. Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study. , 2011, Journal of osteoporosis.
[24] Chao Zhong,et al. A polysaccharide bioprotonic field-effect transistor. , 2011, Nature communications.
[25] V. Yang,et al. Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. , 2011, Biomaterials.
[26] Mary E Napier,et al. More effective nanomedicines through particle design. , 2011, Small.
[27] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[28] D. Patel,et al. Principles of pharmacology. , 2011, Pediatric clinics of North America.
[29] Joseph M. DeSimone,et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.
[30] Patrick A Tresco,et al. Reducing surface area while maintaining implant penetrating profile lowers the brain foreign body response to chronically implanted planar silicon microelectrode arrays. , 2011, Progress in brain research.
[31] Gerd Schneider,et al. Three-dimensional cellular ultrastructure resolved by X-ray microscopy , 2010, Nature Methods.
[32] Justin A. Blanco,et al. Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics. , 2010, Nature materials.
[33] M. Berggren,et al. Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function. , 2009, Nature materials.
[34] Richard D. Leapman,et al. Nanoscale 3D cellular imaging by axial scanning transmission electron tomography , 2009, Nature Methods.
[35] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[36] Giovanni De Micheli,et al. An Outlook on Design Technologies for Future Integrated Systems , 2009, IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems.
[37] F. Collins,et al. The HapMap and genome-wide association studies in diagnosis and therapy. , 2009, Annual review of medicine.
[38] P. Roschger,et al. Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide , 2009, Calcified Tissue International.
[39] Andrew Leis,et al. Visualizing cells at the nanoscale. , 2009, Trends in biochemical sciences.
[40] G. Woodruff,et al. BLOOD FLOW IN ARTERIES , 2009 .
[41] H. Merkle,et al. PEGylation as a tool for the biomedical engineering of surface modified microparticles. , 2008, Journal of pharmaceutical sciences.
[42] M. McGirt,et al. Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience , 2008, Annals of Surgical Oncology.
[43] David F. Williams. On the mechanisms of biocompatibility. , 2008, Biomaterials.
[44] Dong-Yol Yang,et al. Advances in 3D nano/microfabrication using two-photon initiated polymerization , 2008 .
[45] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.
[46] Joseph M DeSimone,et al. Shape-specific, monodisperse nano-molding of protein particles. , 2008, Journal of the American Chemical Society.
[47] B. Clarke,et al. Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Randomized Trial , 2008 .
[48] M. Kameneva,et al. Mechanical degradation of drag reducing polymers in suspensions of blood cells and rigid particles. , 2008, Biorheology.
[49] V. Lukyanenko. Delivery of nano-objects to functional sub-domains of healthy and failing cardiac myocytes. , 2007, Nanomedicine.
[50] James G. Grote,et al. Organic field-effect transistors and memory elements using deoxyribonucleic acid (DNA) gate dielectric , 2007 .
[51] Georg Jakopic,et al. Two-photon 3D lithography: A Versatile Fabrication Method for Com- plex 3D Shapes and Optical Interconnects within the Scope of Innovative Industrial Applications , 2007 .
[52] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[53] N. Laperriere,et al. Gliadel wafers in the treatment of malignant glioma: a systematic review , 2007, Current oncology.
[54] D. Northfelt,et al. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma , 2007, International journal of nanomedicine.
[55] David B Resnik,et al. Ethics in nanomedicine. , 2007, Nanomedicine.
[56] S. Libutti,et al. Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect , 2007, Clinical Cancer Research.
[57] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[58] R. Lindsay,et al. Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis , 2007, Annals of Internal Medicine.
[59] Dong-Yol Yang,et al. Ultraprecise microreproduction of a three-dimensional artistic sculpture by multipath scanning method in two-photon photopolymerization , 2007 .
[60] Victor Frenkel,et al. Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study. , 2007, Thrombosis research.
[61] Robin L. Jones,et al. Anthracycline cardiotoxicity , 2006, Expert opinion on drug safety.
[62] Rein V. Ulijn,et al. Enzyme-responsive materials: a new class of smart biomaterials , 2006 .
[63] Robert Langer,et al. Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.
[64] V. Frenkel,et al. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. , 2006, Academic radiology.
[65] John T Santini,et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device , 2006, Nature Biotechnology.
[66] Dakrong Pissuwan,et al. Therapeutic possibilities of plasmonically heated gold nanoparticles. , 2006, Trends in biotechnology.
[67] R. Hovorka. Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[68] J. Reginster,et al. Osteoporosis: a still increasing prevalence. , 2005, Bone.
[69] Z. Ram,et al. Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial , 2006, Acta Neurochirurgica.
[70] John T Santini,et al. Electrothermally activated microchips for implantable drug delivery and biosensing. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[71] R. Mebius,et al. Structure and function of the spleen , 2005, Nature Reviews Immunology.
[72] Joseph M DeSimone,et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.
[73] C. Porter,et al. Subcutaneous drug delivery and the role of the lymphatics. , 2005, Drug discovery today. Technologies.
[74] R. Langer,et al. Smart Biomaterials , 2004, Science.
[75] D. P. O'Neal,et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.
[76] R. Langer,et al. Designing materials for biology and medicine , 2004, Nature.
[77] A. Santoro,et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[78] Liying Wang,et al. The Transport Barrier of Epithelia: A Comparative Study on Membrane Permeability and Charge Selectivity in the Rabbit , 1992, Pharmaceutical Research.
[79] C. Binder,et al. Pharmacokinetics of continuous subcutaneous insulin infusion , 1983, Diabetologia.
[80] Robert Langer,et al. Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.
[81] Z. Ram,et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. , 2003, Neuro-oncology.
[82] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[83] M. Rubin,et al. New anabolic therapies in osteoporosis , 2002, Endocrinology and metabolism clinics of North America.
[84] E. Beard,et al. The American Society of Health System Pharmacists. , 2001, JONA's Healthcare Law, Ethics, and Regulation.
[85] M. Swartz,et al. The physiology of the lymphatic system. , 2001, Advanced drug delivery reviews.
[86] H. Maeda. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.
[87] C. E. Stiles,et al. Tissue response to single-polymer fibers of varying diameters: evaluation of fibrous encapsulation and macrophage density. , 2000, Journal of biomedical materials research.
[88] R. Müller,et al. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[89] R Panchagnula,et al. Biopharmaceutics and pharmacokinetics in drug research. , 2000, International journal of pharmaceutics.
[90] E. Bonora,et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. , 2000, Diabetes care.
[91] W. Duckworth,et al. Insulin degradation: progress and potential. , 1998, Endocrine reviews.
[92] W. Rodrigueza,et al. Structural and metabolic consequences of liposome-lipoprotein interactions. , 1998, Advanced Drug Delivery Reviews.
[93] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[94] R. Lindsay,et al. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis , 1997, The Lancet.
[95] H. D. Liggitt,et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery , 1997, Nature Biotechnology.
[96] R Langer,et al. Characterization of glucose-mediated insulin release from implantable polymers. , 1996, Journal of pharmaceutical sciences.
[97] P. Volberding,et al. Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.
[98] Y. Barenholz,et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. , 1994, Cancer research.
[99] 和田 八三久. Materials science. , 1973, Science.
[100] G L Amidon,et al. Absorption of peptide and peptidomimetic drugs. , 1994, Annual review of pharmacology and toxicology.
[101] J. Hock,et al. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[102] J. Kost,et al. Responsive polymer systems for controlled delivery of therapeutics. , 1992, Trends in biotechnology.
[103] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[104] R. Langer. Polymer implants for drug delivery in the brain , 1991 .
[105] C. Haanen,et al. Clinical Pharmacokinetics of Doxorubicin , 1988, Clinical pharmacokinetics.
[106] E. Edelman,et al. Controlled Release of Insulin From Polymer Matrices: Control of Diabetes in Rats , 1986, Diabetes.
[107] F. Bellisle,et al. Cephalic phase of insulin secretion and food stimulation in humans: a new perspective. , 1985, The American journal of physiology.
[108] T. M. Hayes,et al. COMPARATIVE STUDY OF SUBCUTANEOUS, INTRAMUSCULAR, AND INTRAVENOUS ADMINISTRATION OF HUMAN INSULIN , 1981, The Lancet.
[109] J. Wagner,et al. History of pharmacokinetics. , 1981, Pharmacology & therapeutics.
[110] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[111] H N Sabbah,et al. Turbulent Blood Flow in the Ascending Aorta of Humans with Normal and Diseased Aortic Valves , 1976, Circulation research.
[112] D. Long,et al. Silicone Rubber: A New Diffusion Property Useful for General Anesthesia , 1966, Science.
[113] Duran Cg,et al. COMBINING THE ANTIDEPRESSANT DRUGS. , 1965 .
[114] J. Folkman,et al. THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. , 1964, The Journal of surgical research.
[115] S. Rose,et al. A continuous long-term injector. , 1955, The Australian journal of experimental biology and medical science.
[116] S. de Jongh,et al. The influence of divided doses of drugs on the duration of effect and integral of effect. , 1950, Acta physiologica et pharmacologica Neerlandica.
[117] A. G. V. van GEMERT,et al. Optimal dosage of drugs. , 1950, Acta physiologica et pharmacologica Neerlandica.
[118] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.